Phase 2 Small Vessel Disease Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 2

GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)

Cerebral Small Vessel Disease

Chinese University of Hong Kong110 enrolled1 locationNCT05356104

Recruiting

Phase 1Phase 2

Retina is a Marker for Cerebrovascular Heath

Cerebral Small Vessel DiseasesCerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and LeukoencephalopathyCerebral Microbleeding+1 more

Mayo Clinic100 enrolled1 locationNCT04753970

Withdrawn

Phase 2

Evaluating Cerebral micro-bleeding cHanges to Optimise anticoagulation thErapy in Stroke patients with Atrial Fibrillation

Cerebral microbleed (CMB)Silent brain infarct (SBI)Cerebral small vessel disease (CSVD)

The George Institute for Global Health200 enrolled1 locationACTRN12623000949684